open access

Vol 14, No 1 (2021)
Review paper
Published online: 2021-09-30
Get Citation

Nephrotoxicity of immune checkpoint inhibitors in immunotherapy of oncologic patients

Katarzyna Szychowska, Katarzyna Szychowska, Ilona Kurnatowska12
Renal Disease and Transplantation Forum 2021;14(1).
Affiliations
  1. Department of Nephrology, University Clinical Hospital No. 1 by the name of N. Barlicki, Lodz, Poland
  2. Internal Diseases and Transplant Nephrology Clinic, I Department of Internal Diseases, Medical University in Lodz, Poland

open access

Vol 14, No 1 (2021)
Prace poglądowe
Published online: 2021-09-30

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

checkpoints inhibitors, kidney injury

About this article
Title

Nephrotoxicity of immune checkpoint inhibitors in immunotherapy of oncologic patients

Journal

Renal Disease and Transplantation Forum

Issue

Vol 14, No 1 (2021)

Article type

Review paper

Published online

2021-09-30

Bibliographic record

Renal Disease and Transplantation Forum 2021;14(1).

Keywords

checkpoints inhibitors
kidney injury

Authors

Katarzyna Szychowska
Katarzyna Szychowska
Ilona Kurnatowska

References (17)
  1. Perazella MA, Shirali AC. Immune checkpoint inhibitor nephrotoxicity: what do we know and what should we do? Kidney Int. 2020; 97(1): 62–74.
  2. Perazella MA, Shirali AC. Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future. J Am Soc Nephrol. 2018; 29(8): 2039–2052.
  3. Oleas D, Bolufer M, Agraz I, et al. Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience. Clin Kidney J. 2021; 14(5): 1364–1370.
  4. Khwaja A. KDIGO Clinical Practice Guidelines for Acute Kidney Injury. Nephron. 2012; 120(4): c179–c184.
  5. Cortazar FB, Kibbelaar ZA, Glezerman IG, et al. Clinical Features and Outcomes of Immune Checkpoint Inhibitor-Associated AKI: A Multicenter Study. J Am Soc Nephrol. 2020; 31(2): 435–446.
  6. Sise ME, Seethapathy H, Reynolds KL. Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Renal Toxicity: Illustrative Case and Review. Oncologist. 2019; 24(6): 735–742.
  7. Kostine M, Rouxel L, Barnetche T, et al. FHU ACRONIM. Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study. Ann Rheum Dis. 2018; 77(3): 393–398.
  8. Meraz-Muñoz A, Amir E, Ng P, et al. Acute kidney injury associated with immune checkpoint inhibitor therapy: incidence, risk factors and outcomes. J Immunother Cancer. 2020; 8(1).
  9. Malyszko J, Tesarova P, Capasso G, et al. The link between kidney disease and cancer: complications and treatment. Lancet. 2020; 396(10246): 277–287.
  10. Shingarev R, Glezerman IG. Kidney Complications of Immune Checkpoint Inhibitors: A Review. Am J Kidney Dis. 2019; 74(4): 529–537.
  11. Malyszko J, Lee MW, Capasso G, et al. How to assess kidney function in oncology patients. Kidney Int. 2020; 97(5): 894–903.
  12. Brahmer JR, Lacchetti C, Thompson JA, et al. National Comprehensive Cancer Network. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018; 36(17): 1714–1768.
  13. Strohbehn IA, Lee M, Seethapathy H, et al. Safety and Efficacy of Immune Checkpoint Inhibitors in Patients on Dialysis: A Retrospective Case Series. Am J Kidney Dis. 2020; 76(2): 299–302.
  14. Grzejszczak P, Kurnatowska I. Czynniki ryzyka oraz epidemiologia nowotworów u chorych po przeszczepach narządowych. in: Durczyński A, Hogendorf P (red.) Nowotwory po przeszczepieniu narządów. Biblioteka chirurga onkologa. Tom 19. Via Medica Gdańsk. ; 2020: 3–10.
  15. Kumar V, Shinagare AB, Rennke HG, et al. The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature. Oncologist. 2020; 25(6): 505–514.
  16. Manohar S, Thongprayoon C, Cheungpasitporn W, et al. Systematic Review of the Safety of Immune Checkpoint Inhibitors Among Kidney Transplant Patients. Kidney Int Rep. 2020; 5(2): 149–158.
  17. Venkatachalam K, Malone AF, Heady B, et al. Poor Outcomes With the Use of Checkpoint Inhibitors in Kidney Transplant Recipients. Transplantation. 2020; 104(5): 1041–1047.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.